Asaia Lannensis Bacteremia in a ‘Needle Freak’ Patient

Asaia Lannensis Bacteremia in a ‘Needle Freak’ Patient

CASE REPORT For reprint orders, please contact: [email protected] Asaia lannensis bacteremia in a ‘needle freak’ patient Edoardo Carretto*,1, Rosa Visiello1, Marcellino Bardaro1, Simona Schivazappa2, Francesca Vailati3, Claudio Farina3 & Daniela Barbarini4 The genus Asaia has gained much interest lately owing to constant new species discoveries and its role as a potential opportunistic pathogen to humans. Here we describe a transient bacteremia due to Asaia lannensis in a patient with a psychiatric disorder (compulsive self- injection of different substances). Common phenotypic methods of identification failed to identify this organism, and only restriction fragment lenght polymorphism of PCR-amplified 16S rRNA gene allowed for proper identification. The isolate was highly resistant to most antibiotics. The paper also discusses the currently available medical literature, acknowledges the potential problems linked to the isolation of these strains and proposes an approach to species identification that can be applied in a clinical microbiology laboratory. First draft submitted: 7 April 2015; Accepted for publication: 8 October 2015; Published online: 17 December 2015 A 28-year-old female patient, known to have psychiatric problems (compulsive self-injection of dif- KEYWORDS ferent substances), was admitted by the Emergency Department of the IRCCS Arcispedale Santa • Asaia • Asaia lannensis Maria Nuova of Reggio Emilia, Italy, due to pyrexia, with a temperature exceeding 40°C the night • bacteremia • clinical before the admission. As self-medication the patient took paracetamol early in the morning, and at significance• molecular the moment of admission her temperature was 37.8°C, with a blood pressure of 100/60 mmHg. The identification patient declared that during the night she had taken lorazepam for insomnia, dissolving the 2.5 mg capsule in water of unknown origin before self-injecting it intravenously. On physical examination, the patient appeared alert and somewhat orientated, with 98% oxygen saturation. No pathological signs were observed; cardiovascular, neurological and pulmonary systems were normal. Bilateral inguinal venepuncture lesions were noted. From the biochemical point of view, she showed only a mild leucocytosis with 13,050 cells/mm3 with a slight normochromic normocytic anemia and other parameters within the corresponding normal range. Procalcitonin was 0.34 ng/ml and C-reactive protein was 2.5 mg/dl. Two different blood cultures (aerobic and anaerobic bottles) were collected and the patient was discharged with a course of amoxicillin-clavulanate and referred to the Infectious Disease Department for follow-up, however, she disappeared for long-term controls. Blood culture samples were analyzed using the BACTEC FX system (Beckton Dickinson, USA). Three days and 22 h after the beginning of the analysis, a single aerobic bottle of the two sets col- lected was reported as positive by the instrument. The sample was plated on common agar media. After 48 h short Gram-negative aerobic bacilli grew on Columbia blood agar and chocolate agar, incubated at 36°C in air and 5%CO2, respectively. Two days after small colonies also appeared 1Clinical Microbiology Laboratory – IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy 2Infectious Diseases – IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy 3Microbiology & Virology Laboratory – Azienda Ospedaliera ‘Papa Giovanni XXIII,’ Bergamo, Italy 4Virology & Microbiology Laboratory – Fondazione IRCCS Policlinico San Matteo, Pavia, Italy *Author for correspondence: Tel.: +39 052 229 6363; Fax: +39 052 229 6750; [email protected] part of 10.2217/fmb.15.126 © 2016 Future Medicine Ltd Future Microbiol. (Epub ahead of print) ISSN 1746-0913 CASE REPORT Carretto, Visiello, Bardaro et al. on McConkey agar (incubated at 36°C in air doubtful profile (code 4040000, T-index of less ambient); no growth was observed on manni- than 0.33 for different genera such as Pasteurella tol salt agar (MSA). On Columbia blood agar spp. and Acinetobacter lwoffii). API-32GN pro- the colonies appeared pale rose, shiny, smooth vided a good identification ofEscherichia coli and raised with an entire margin (Figure 1A). (code 00003400000, T-index = 0.82). At this After the passing of time, the colonies appeared point, an API-50CH (bioMérieux, France) was enlarged and more pigmented (Figure 1B). The performed, according to the manufacturer’s isolate was oxidase, coagulase and urease nega- instructions, to evaluate the ability of the strain tive, and catalase positive. Vitek2™ (bioMé- to produce acid for different substrates. rieux, France) was initially used (GN card) to The organism was also analyzed by using the identify the strain and perform antimicrobial matrix-assisted laser desorption/ionization–time susceptibility testing. Contemporaneously, ASTs of flight (MALDI-TOF) technology. Initially, were also performed by using the disc diffusion the Bruker Biotyper Plus™ (Bruker, USA) method (Kirby Bauer) on Mueller Hinton agar instrument was used. The database of strains and on Mueller Hinton agar with 5% sheep available for diagnostic purposes in clinical blood (MHSB). After 6.75 h, Vitek2™ iden- microbiology laboratories (i.e., the CE-IVD tified the micro-organism asShigella species approved software) was unable to provide iden- (bionumber: 2005410520101210, good identi- tification: different experiments performed after fication), but the system did not provide sus- the procedure of strain extraction proposed a ceptibility test results. The micro-organism on list of various micro-organisms with an identi- MHSB was extremely resistant (since it was slow fication score of less than 1.3 (no reliable iden- growing the results were evaluated after 48-h tification). The strain was then referred to the incubation at 36°C, air ambient). The growth Azienda Ospedaliera ‘Papa Giovanni XXIII’ in characteristics, the negativity of the agglutina- Bergamo, where the MALDI-TOF analysis was tion with Shigella antisera and the highly resist- performed using the Vitek™ MS (BioMérieux, ant susceptibility profile allowed us to exclude France). However, this system also was unable the isolate as belonging to the Shigella group. to identify the organism using the database Thus, API-20E, API20-NE and API-32GN approved for diagnostic purposes. (bioMérieux, France), were set up according to Since all the tests performed at this point the manufacturer’s instructions and, contempo- were unable to provide correct identification raneously E-test methodology (MIC test strip™, of the strain, genotypical identification was Liofilchem, Italy) was performed to obtain MICs performed by amplification and sequencing of to different antimicrobials for the isolate. a DNA fragment encoding for the 16S rRNA The isolate showed high MICs for most of gene, according with the manufacturers’ sug- the antibiotics tested. It was highly resistant gestions (Applied Biosystems, USA). The 1500 to all the β-lactams and to chloramphenicol, bp sequence obtained was compared with fluoroquinolones, colistin, cotrimoxazole and those present in GenBank using the BLASTn vancomycin. Instead, it was susceptible to the program and a similarity of 99.9% (1412 out aminoglycosides (amikacin, gentamycin and of 1413 bases) was found with the genome of tobramycin), and to tetracycline. Since the strain Asaia lannensis strain NBRC 102526 (GenBank presented with the peculiar characteristics men- accession number: NR_114144.1) and of Asaia tioned above, we evaluated the antimicrobial lannensis strain AB92 (GenBank accession num- susceptibilities using the breakpoints proposed ber: NR_041564.1, 1410 out of 1411 bases). The by the Interpretive Standards for the Minimal sequence of our isolate was then deposited in the Inhibitory Concentration (MIC) for Other GenBank database with the accession number Non-Enterobacteriaceae provided by CLSI [1] . KP208318. All the resistant drugs showed a high-level resist- The taxonomy and the lineage reports were ance profile with confluent growth around the consistent with the genus Asaia, but differ- MIC test strips. ent matches within the species of the genus The API-20E generated a doubtful profile were possible. A similarity of 99.6% (1407 (code 0004252, T-index of less than 0.30 for out of 1413 bases) was found with A. bogore- different genera such as Klebsiella spp., Shigella nsis NBRC 103511 (GenBank accession num- spp., Escherichia coli and Acinetobacter bau- ber: AB682098.1), 99.4% (1425 out of 1433 mannii complex). Also the API-20NE gave a bases) with an uncultured Asaia species clone 10.2217/fmb.15.126 Future Microbiol. (Epub ahead of print) future science group Asaia lannensis bacteremia in a ‘needle freak’ patient CASE REPORT Figure 1. Strains growth on Columbia blood agar, incubation at 36°C air ambient, after 72 h (A) and 7 days (B). (GenBank accession number: KF414320.1) and as A. lannaensis), A. siamensis, A. krugthepen- 99.4% (1425 out of 1434 bases) with A. plat- sis, A. astilbis, A. platycodi, A. prunellae and A. ycodi, GenBank accession number JF514557.1. spathodeae [2,3,5,7–9]. All of these species were At this point, the restriction fragment length originally isolated from tropical flowers, orchid polymorphism technique (RFLP) of PCR- trees or from fermented glutinous rice found in amplified 16S rRNA gene was utilized, which south-east Asia [10], even if they have been found was demonstrated to being able in distinguish- worldwide, thus being considered nowadays as ing among the species

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    7 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us